GL1X · GenesisL1 explorer

Research workbench

Human B-RAF kinase domain in complex with an imidazopyridine-based inhibitor

Analyse Human B-RAF kinase domain in complex with an imidazopyridine-based inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MBJ
Type
protein
Length
545 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase B-RAF
EC
2.7.11.1
UniProt
P15056
Ligands
DFS
Pockets
8 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 36% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase B-RAF (EC 2.7.11.1)protein26936% helix, 13% strandP15056
BSERINE/THREONINE-protein kinase B-RAF (EC 2.7.11.1)protein27636% helix, 12% strandP15056

Ligands and binding sites

  • DFS · 2,6-difluoro-N-(1H-imidazo[4,5-b]pyridin-6-yl)-3-[(propylsulfonyl)amino]benzamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16170.770.8366DFS
23650.710.8334DFS
31770.610.8333empty
4610.600.9121empty
51900.540.7928empty

Interfaces

1 interface between chains.

  • A–B · 1179 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 4MBJ · Human B-Raf Kinase Domain in Complex with an Imidazopyridine-based Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P15056 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase B-RAF (P15056) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.